Innoventions Ltd. posted this:Novel Emboli Capturing and Removal Double-Filtering System for Whole-Body Prevention of Embolic Complications During and After TAVI / TAVR ProceduresInnoventions' proprietary novel Emboli Capturing and Removal Double-Filtering System, integrated to TAVI/TAVR delivery system is for total double-filtration and collection of the embolic particles during the procedure and removing them from the body a the end of the procedure. Differing from the current emboli deflection devices which deflect the embolic particles for preventing cerebrovascular embolic complications, our device prevents dispersion of the embolic material and prevents them reaching all body organs. As such, with our device we are bringing a much more secure and effective solution than the currently used devices.
EPIC Semiconductors posted this:
- at EPIC Semiconductors
OTRI-Universidad de Málaga posted this:
Technology Transfer Office (TTO) at Universidad de Málaga
Covid-19 Innovation Challenges by Innoget posted this:Shimmer3 Bioimpedance Monitor - Monitoring HR, respiration rate and depth, and the increase in fluid in the lungs to triage and remotely monitor Covid-19 patientsManaging the huge influx of patients in hospitals is one of the most critical challenges of the current COVID-19 pandemic. Shimmer’s Bioimpedance Monitor has the potential to help manage this challenge by monitoring HR, respiration rate and depth and the increase in fluid in the lungs to triage and remotely monitor patients. Background Bioimpedance, specifically across the lungs, has long been studied in Chronic Heart Failure (CHF) and Acute Respiratory Distress Syndrome (ARDS). This measurement provides useful indicators of respiration, including rate, volume, and fluid in the lungs. Because COVID-19 attacks the lungs, these measurements provide clear indications of the progression of the disease. This information can be used in many ways, potentially including: • Monitoring patients remotely at home to determine, if and when, they will need to be admitted to the hospital • Monitoring patients in a hospital to determine when they need more aggressive treatment (e.g., ventilators) • Enabling the earlier release of non-acute patients because of the ability to monitor at home • Adjusting the treatment depending on the rate of progression of disease
Alireza Daneshvar posted this:
Pharmacy Student and Researcher at Tehran University of Medical Sciences
Pascal Mayer posted this:
CEO at Alphanosos
Universitat Politècnica de Catalunya - UPC posted this:Cardiovascular health assessment from a common electronic weighing scaleAn easy-to-use and affordable system able to quickly assess physiological parameters related to cardiac and vascular health of a subject from the force sensors of a common electronic weighing scale.
Universitat Politècnica de Catalunya - UPC posted this:Fast cardiovascular condition assessmentAn easy-to-use and affordable system able to determine several cardiovascular parameters from unsupervised measurements easily obtained at hands or feet.
Universitat Politècnica de Catalunya - UPC posted this:Novel conic cannula for spine cement injectionNovel conic cannula for homogeneous injection of bone cements in the spine have been patented and developed. The new design is especially indicated for the injection of ceramic-based bone cements because the pressure drop developed along the cannula minimizes bone cement’s press filtering. Partners to further develop the technology and/or to establish commercial agreements along with technical cooperation are sought.
Universitat Politècnica de Catalunya - UPC posted this:SELF DRIVEN MICROFLUIDIC FILTER FOR SEPERATING LIQUID FROM A LIQUID INCLUDING DEFORMABLE PARTICLES (I.E. PLASMA FROM BLOOD)This Novel Microfluidic circuit has been developed in MicroTechLab of the Mechanical Engineering Department of UPC. Currently, partners to further develop the system and/or to establish commercial agreements along with technical cooperation are sought.
Universitat Politècnica de Catalunya - UPC posted this:BIOFEEDBACK SYSTEM FOR URINARY INCONTINENCE TREATMENTThis new biofeedback has been developed by the division of Biomedical Signals and Systems and the division of Instrumentation and Bioengineering at CREB UPC and the support of the Hospital Clínic.
Universitat Politècnica de Catalunya - UPC posted this:Non-invasive method to objectively determine the dynamics of the tear film and diagnose dryeye disease (DED)A new system for the assessment of the tear film quality and the diagnosis of dry-eye has been developed. Based on a non-invasive recording of images of the light reflected on the tear-film of the eye, posterior image processing allows the objective assessment of dry-eye condition. It’s a simple and cost-effective system easy to use in clinics.
Universitat Politècnica de Catalunya - UPC posted this:Tantalum foams for orthopaedic applicationsA method for obtaining Tantalum (Ta) foams through the powder metallurgy technique for trabecular bone implants has been patented and developed. Partners to further develop the system and/or to establish commercial agreements along with technical cooperation are sought.
Universitat Politècnica de Catalunya - UPC posted this:A device for electromechanical stimulation of 2D monolayer and 3D stem cell’s cultures for tissue engineering applicationsNew device and apparatus for mechanical or simultaneous electromechanical stem cell cultures have been designed and patented by UPC and IGTP. The device is disposable and allows sterile mechanical stimulation on standard Petri dishes without breaking the sterile barrier. Partners to further develop the system and/or to establish commercial agreements along with technical cooperation are sought.
Universitat Politècnica de Catalunya - UPC posted this:Biopolymer-containing calcium phosphate foam for bone regenerationThe Challenge Hidroxyapatyte is a natural mineral found in teeth and bones. It is commonly used as a filler to regenerate bone or as a coating to promote bone growth. The application of calcium phosphate cements, which can form hydoxyapatite, in the treatment of bone defects, begun more than two decades ago and many formulations have been developed so far. The ideal bone replacing cement should be osteoconductive and osteoinductive, to stimulate bone regeneration. Moreover, it should be resorbable and gradually replaced by newly formed bone. Although most of the developed calcium phosphate cements are more resorbable than sintered hydroxypatite ceramics, they still show relatively slow resorption kinetics and in many cases the cement remains stable in the implanted site during years. The absence of interconnected macropores is indeed a limiting factor to achieve resorption. If the designed material has macropores, cells can colonize it and the access of osteoclasts is facilitated increasing the rate of healing of the bone defect.